Cannabis: WHO just acknowledged historical misjudgment and heads towards global policy update

After thoroughly assessing Cannabis, THC and CBD in June, the WHO has just recognized its historical misjudgment that led to the placement of Cannabis medicines among heroin or fentanyl derivates, and will consider an international change of scheduling to adequate policies with evidence. #ECDD40

Press release: WHO & Cannabis – 40th ECDD meeting

PRESS RELEASE • Cannabis policy reform: Activists from all continents converge in Geneva – Historical day inside of the World Health Organization.

Human Rights violations in the name of Drug Control: contribution to UN Human Rights

57 years of Global and Systematic Human Rights violations in the name of #DrugControl: Right to a Remedy and Reparation for Victims of Gross Violations of International Human Rights Law.

[VIDEO] Hepatitis C among people who use drugs, Governments & the UN.

FAAAT co-hosted, last March at the United Nations, a consensus conference where governments and representative of drug users discussed the global state of Hepatitis C and recommendations raised from the practice. Video and track record.

Cannabis review by the WHO: all you need to know

In 2018 for the first time, the World Health Organization is assessing the medical uses and harms of Cannabis, and will recommend the suitable classification to be applied internationally. We promote an objective and independent assessment, that recognizes and acknowledges modern research on Cannabis. Support us!

Will modern drug policies come from Norway?

The Norwegian Association for Safer Drug Policies, FAAAT and 20 policymakers and stakeholders from 10 countries recalled that Norway should be a model for the rest of the world’s drug policy reforms.

Pin It on Pinterest